Next-gen Lap-Band
This article was originally published in The Gray Sheet
Executive Summary
Allergan's Lap-Band AP adjustable gastric band for use in weight-loss surgery in severely obese adults will launch in the United States July 2. The device, which wraps around and constricts the stomach, improves upon the 2001-approved Lap-Band, which generated nearly $131 million in sales last year, by distributing pressure evenly throughout its 360-degree inflation area, the firm says (1"The Gray Sheet" March 19, 2007, p. 14)...
You may also be interested in...
Broad Coverage For Lap-Band Helps Grow Allergan’s Obesity Sales
CMS' decision to cover Allergan's Lap-Band laparoscopic adjustable gastric band for Medicare beneficiaries last February helped spark a 33% revenue jump for Allergan's obesity intervention business in 2006
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.